Integer Holdings (ITGR) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Integer Holdings Corporation  (NYSE: ITGR)

Select the Financial Report: Select the Period:


Description of Integer Holdings's Business Segments


Integer Holdings Corporation operates with a strategic focus on two key segments: Medical and Non-Medical. Each segment encompasses a diverse range of products and services tailored to meet the unique needs of their respective markets.

Segments:

1. Medical Segment
The Medical Segment of Integer Holdings Corporation is dedicated to the design, development, and manufacturing of advanced products and services aimed at addressing a variety of medical needs. This segment serves several critical areas in healthcare:

- Cardiology: This division specializes in products that facilitate the diagnosis and treatment of cardiovascular diseases. The product line includes:
- Diagnostic Catheters: Used for the assessment of heart conditions and for procedures that require access to the cardiovascular system.
- Electrophysiology Catheters: Utilized in the mapping and treatment of arrhythmias, these catheters are essential tools for electrophysiology studies and ablation procedures.
- Other Cardiac Devices: This may include implantable devices and systems intended for long-term cardiac monitoring and therapy.

- Neuromodulation: Recognizing the increasing prevalence of neurological disorders, this division offers products that cater to the treatment of conditions such as:
- Spinal Cord Stimulation Systems: These devices are designed to relieve chronic pain through electrical stimulation of the spinal cord.
- Deep Brain Stimulation Systems: Used primarily in the treatment of movement disorders, these systems deliver targeted electrical impulses to specific brain regions.
- Neurostimulation Devices: Additional devices aimed at treating epilepsy and other neurological conditions, providing therapeutic benefits through neuromodulation techniques.

- Vascular and Structural Heart: This division focuses on innovative solutions for vascular interventions and structural heart repairs, thereby improving patient outcomes. Product offerings include:
- Catheter-Based Delivery Systems: Devices specifically designed for the precise delivery of therapies within the vascular system.
- Occlusion Devices: Products that assist in occluding blood vessels during surgical procedures to manage blood flow.
- Embolic Protection Products: Devices that protect against embolisms during interventions and assist in maintaining blood flow to critical areas.

- Advanced Surgical: This division equips healthcare providers with necessary surgical tools and instruments, which include:
- Laparoscopic and Endoscopic Surgical Instrumentation: Specialized instruments used in minimally invasive surgeries.
- Disposable Biopsy Forceps: Tools designed for obtaining tissue samples during endoscopic procedures.
- Other Disposable Surgical Devices: A range of single-use surgical items that ensure sterility and minimize the risk of infection in surgical settings.

Non-Medical Segment
The Non-Medical Segment of Integer Holdings Corporation focuses on providing high-performance battery solutions and customized industrial technologies. This segment is vital for clients across various industries:

- Battery Division: This division is dedicated to the development of advanced battery solutions that are engineered for demanding environments and applications. Key offerings include:
- High-Performance Batteries: Suitable for applications in military and aerospace, offering reliability and durability in critical operations.
- Capacitors: Designed for energy storage and power management across a variety of devices, including medical equipment.

- Industrial Division: This division offers tailored solutions designed for diverse industrial applications, emphasizing quality and innovation. Services include:
- Machining and Fabrication: Providing customized manufacturing services to meet specific client requirements.
- Engineering Services: Collaborative development processes aimed at creating functionality-driven designs for industrial applications.
- Testing Services: Ensuring product performance and reliability through rigorous testing protocols that meet industry standards.

Overall Value Proposition
Integer Holdings Corporation is committed to enhancing the quality of life for patients through its innovative medical products and services while supporting industrial clients with customized, high-performance solutions. The companys focus on research, development, and production is driven by a commitment to quality, cost-effectiveness, and sustainability, making it a leader in both segments. Their emphasis on innovation ensures continuous improvement in technology and product offerings, aligning with the dynamic needs of the markets they serve.


Composition of Integer Holdings Corporation Revenues by Segments

 
Cardio and Vascular    116.79 % of total Revenue
Cardiac Rhythm Management & Neuromodulation    73.68 % of total Revenue
Other Markets    4.24 % of total Revenue

Q2 three months ended (Jul 03 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Cardio and Vascular 542.04 116.79 %
Cardiac Rhythm Management & Neuromodulation 341.98 73.68 %
Other Markets 19.67 4.24 %
Total 464.11 100 %




Q2 three months ended (Jul 03 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Cardio and Vascular - -
Cardiac Rhythm Management & Neuromodulation - -
Other Markets 11.52 % 105.29 %
Total -2.53 % 5.82 %




Q2 three months ended (Jul 03 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total 23.61 5.09 %




Q2 three months ended (Jul 03 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total -36.22 % 43.01 %




Annual Report on Integer Holdings Corporation Divisions, Sales by Country

 
Other Markets   Other Markets Segment contribution to total sales 4.2 % of total Revenue
Cardio Vascular   Cardio Vascular Segment contribution to total sales 59.73 % of total Revenue
Cardiac Rhythm Management Neuromodulation   Cardiac Rhythm Management Neuromodulation Segment contribution to total sales 36.09 % of total Revenue
Reportable Segment   Reportable Segment Segment contribution to total sales 100.01 % of total Revenue
U S   U S Segment contribution to total sales 52.87 % of total Revenue
Costa Rica   Costa Rica Segment contribution to total sales 9.36 % of total Revenue
Puerto Rico   Puerto Rico Segment contribution to total sales 7.08 % of total Revenue
Ireland   Ireland Segment contribution to total sales 5.35 % of total Revenue
Rest of world   Rest of world Segment contribution to total sales 25.35 % of total Revenue


Twelve months ended 2025
ITGR s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Other Markets 77.75 4.2 %
Total 1,853.39 100 %
Cardio Vascular 1,107.08 59.73 %
Cardiac Rhythm Management Neuromodulation 668.80 36.09 %
Reportable Segment 1,853.64 100.01 %
U S 979.81 52.87 %
Costa Rica 173.52 9.36 %
Puerto Rico 131.26 7.08 %
Ireland 99.16 5.35 %
Rest of world 469.89 25.35 %


Twelve months ended 2025
ITGR s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total 102.81 5.55 %
Reportable Segment 500.39 26.99 %

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Other Markets -26.93 % -
Total 8.01 % -14.25 %
Cardio Vascular 16.59 % -
Cardiac Rhythm Management Neuromodulation 1.24 % -
Reportable Segment 7.98 % 9.01 %
U S 4.38 % -
Costa Rica 39.16 % -
Puerto Rico -4.23 % -
Ireland 17.48 % -
Rest of world 8.83 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.